Changing the Treatment of Permanent Neonatal Diabetes Mellitus from Insulin to Glibenclamide in a 4-Month-Old Infant with KCNJ11 Activating Mutation

Permanent neonatal diabetes mellitus (PNDM) is a rare type of diabetes and KCNJ11 gene activating mutation is one of its prevalent causes. We introduced a 4-month-old male infant with poor feeding, restlessness, tachypnea, hyperglycemia, metabolic acidosis, and ketonemia. He was discharged with insu...

Descripción completa

Detalles Bibliográficos
Autores principales: Ilkhanipoor, Homa, Karamizadeh, Zohreh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2013
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3793492/
https://www.ncbi.nlm.nih.gov/pubmed/24130952

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3793492/
https://www.ncbi.nlm.nih.gov/pubmed/24130952

Ejemplares similares